Surgical Management of Vascular anomalies

被引:0
作者
Dasgupta R. [1 ]
机构
[1] Division of Pediatric General and Thoracic Surgery, Cincinnati Childrens Medical Center, 3333 Burnet Ave, ML2023, Cincinnati, 45229, OH
关键词
Arteriovenous malformations; Hemangioma; Kaposiform hemangioendothelioma; Lymphatic malformation; Venous malformation;
D O I
10.1007/s40136-014-0066-5
中图分类号
学科分类号
摘要
Vascular anomalies have been historically divided into tumors and malformations based on the Mulliken and Glowacki classification system. Vascular malformations are also further subdivided into simple and combined based on vessel types. Surgical treatment has historically been the mainstay of treatment. With the advent of multi-disciplinary vascular anomaly clinics, the use of novel medical treatments, and the increased use of sclerotherapy, the role of surgery has been refined. Surgery is often now used in combination with other therapies and remains an integral tool for the management of the patient with vascular anomalies. © 2014, Springer Science+Business Media New York.
引用
收藏
页码:285 / 291
页数:6
相关论文
共 41 条
[1]  
Mulliken J.B., Glowacki J., Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics, Plast Reconstr Surg, 69, pp. 412-422, (1982)
[2]  
Enjolras O., Deffrennes D., Borsik M., Diner P., Laurian C., Vascular “tumors” and the rules of their surgical management, Ann Chir Plast Esthet, 43, pp. 455-489, (1998)
[3]  
Metry D., Heyer G., Hess C., Garzon M., Haggstrom A., Frommelt P., Adams D., Siegel D., Hall K., Powell J., Frieden I., Drolet B., Conference P.S.R., Consensus Statement on Diagnostic Criteria for PHACE Syndrome, Pediatrics, 124, pp. 1447-1456, (2009)
[4]  
Hartzell L.D., Buckmiller L.M., Current management of infantile hemangiomas and their common associated conditions, Otolaryngol Clin North Am, 45, pp. 545-556, (2012)
[5]  
Greene A.K., Liu A.S., Mulliken J.B., Chalache K., Fishman S.J., Vascular anomalies in 5,621 patients: guidelines for referral, J Pediatr Surg, 46, pp. 1784-1789, (2011)
[6]  
Drolet B.A., Frommelt P.C., Chamlin S.L., Haggstrom A., Bauman N.M., Chiu Y.E., Chun R.H., Garzon M.C., Holland K.E., Liberman L., Maclellan-Tobert S., Mancini A.J., Metry D., Puttgen K.B., Seefeldt M., Sidbury R., Ward K.M., Blei F., Baselga E., Cassidy L., Darrow D.H., Joachim S., Kwon E.K., Martin K., Perkins J., Siegel D.H., Boucek Rj Frieden I.J., Initiation and use of propranolol for infantile hemangioma: Report of a consensus conference, Pediatrics, 131, pp. 128-140, (2013)
[7]  
Mulliken J.B., Enjolras O., Congenital hemangiomas and infantile hemangioma: missing links, J Am Acad Dermatol, 50, pp. 875-882, (2004)
[8]  
Lee P.W., Frieden I.J., Streicher J.L., McCalmont T., Haggstrom A.N., Characteristics of noninvoluting congenital hemangioma: a retrospective review, J Am Acad Dermatol, 70, pp. 899-903, (2014)
[9]  
Berenguer B., Mulliken J.B., Enjolras O., Boon L.M., Wassef M., Josset P., Burrows P.E., Perez-Atayde A.R., Kozakewich H.P., Rapidly involuting congenital hemangioma: clinical and histopathologic features, Pediatr Dev Pathol, 6, pp. 495-510, (2003)
[10]  
Hynes S., Narasimhan K., Courtemanche D.J., Arneja J.S., Complicated infantile hemangioma of the lip: outcomes of early versus late resection, Plast Reconstr Surg, 131, pp. 373e-379e, (2013)